BioStem Technologies, Inc. (BSEM) income statement
BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
BioStem Technologies, Inc. financial ratios
See a number that looks wrong?